Atherosclerosis Is an Epigenetic Disease

Area of Science:

• Cardiovascular Science
• Epigenetics
• Molecular Biology

Background:

• Atherosclerosis is a chronic inflammatory disease characterized by lipid deposition, leading to acute cardiovascular events.
• Epigenetic mechanisms, including DNA methylation, histone modification, and noncoding RNAs, are increasingly recognized for their role in disease pathogenesis.
• Understanding these epigenetic factors is crucial for developing novel therapeutic interventions.

Purpose of the Study:

• To review the role of epigenetic processes in atherosclerosis progression and plaque vulnerability.
• To highlight the therapeutic potential of epigenetic drugs in managing cardiovascular diseases.

Main Methods:

• Literature review of recent studies on epigenetics and atherosclerosis.
• Analysis of molecular mechanisms underlying epigenetic modifications in cardiovascular disease.
• Evaluation of preclinical and clinical data on epigenetic drug efficacy.

Main Results:

• Epigenetic modifications significantly influence key pathways in atherosclerosis development.
• Specific epigenetic marks are associated with plaque instability and rupture.
• Epigenetic drugs demonstrate potential in modulating atherosclerotic processes.

Conclusions:

• Epigenetic dysregulation is a critical factor in atherosclerosis.
• Targeting epigenetic mechanisms represents a promising therapeutic avenue for cardiovascular therapeutics.
• Further research into epigenetic drugs could lead to improved patient outcomes in cardiovascular disease.